UGT genomic diversity: beyond gene duplication

被引:117
作者
Guillemette, Chantal [1 ]
Levesque, Eric
Harvey, Mario
Bellemare, Judith
Menard, Vincent
机构
[1] CHUQ Res Ctr, Pharmacogen Lab, Canada Res Chair Pharmacogen, Quebec City, PQ G1V 4G2, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
HUMAN UDP-GLUCURONOSYLTRANSFERASES; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; MESSENGER-RNA EXPRESSION; ACTIVATED-RECEPTOR-ALPHA; COPY-NUMBER-VARIATION; PREGNANE-X RECEPTOR; HUMAN-LIVER; PROSTATE-CANCER; DELETION POLYMORPHISM; IN-VITRO;
D O I
10.3109/03602530903210682
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human uridine diphospho (UDP)-glucuronosyltransferase (UGT) superfamily comprises enzymes responsible for a major biotransformation phase II pathway: the glucuronidation process. The UGT enzymes are located in the endoplasmic reticulum of almost all tissues, where they catalyze the inactivation of several endogenous and exogenous molecules, including bilirubin, sex steroids, numerous prescribed drugs, and environmental toxins. This metabolic pathway is particularly variable. The influence of inheritable polymorphisms in human UGT-encoding genes has been extensively documented and was shown to be responsible for a fraction of the observed phenotypic variability. Other key genomic processes are likely underlying this diversity; these include copy-number variations, epigenetic factors, and newly discovered splicing mechanisms. This review will discuss novel molecular aspects that may be determinant to UGT phenotypes.</.
引用
收藏
页码:24 / 44
页数:21
相关论文
共 134 条
[1]   Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation [J].
Al-Romaih, Khaldoun ;
Somers, Gino R. ;
Bayani, Jane ;
Hughes, Simon ;
Prasad, Mona ;
Cutz, Jean-Claude ;
Xue, Hui ;
Zielenska, Maria ;
Wang, Yuzhuo ;
Squire, Jeremy A. .
CANCER CELL INTERNATIONAL, 2007, 7 (1)
[2]   Serial Analysis of Gene Expression (SAGE): 13 Years of Application in Research [J].
Anisimov, Sergey V. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2008, 9 (05) :338-350
[3]   ANALYSIS OF GENES FOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE IN GILBERTS-SYNDROME [J].
AONO, S ;
ADACHI, Y ;
UYAMA, E ;
YAMADA, Y ;
KEINO, H ;
NANNO, T ;
KOIWAI, O ;
SATO, H .
LANCET, 1995, 345 (8955) :958-959
[4]   IDENTIFICATION OF DEFECT IN THE GENES FOR BILIRUBIN UDP-GLUCURONOSYL-TRANSFERASE IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME TYPE-II [J].
AONO, S ;
YAMADA, Y ;
KEINO, H ;
HANADA, N ;
NAKAGAWA, T ;
SASAOKA, Y ;
YAZAWA, T ;
SATO, H ;
KOIWAI, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) :1239-1244
[5]   Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers [J].
Aueviriyavit, Sasitorn ;
Furihata, Tomomi ;
Morimoto, Kaori ;
Kobayashi, Kaoru ;
Chiba, Kan .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) :391-398
[6]  
Barbier O, 2000, DRUG METAB DISPOS, V28, P497
[7]   Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C-19 steroids [J].
Beaulieu, M ;
Levesque, E ;
Hum, DW ;
Belanger, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22855-22862
[8]   Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans [J].
Bélanger, A ;
Pelletier, G ;
Labrie, F ;
Barbier, O ;
Chouinard, S .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (10) :473-479
[9]   Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues [J].
Bélanger, A ;
Hum, DW ;
Beaulieu, M ;
Lévesque, E ;
Guillemette, C ;
Tchernof, A ;
Bélanger, G ;
Turgeon, D ;
Dubois, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 65 (1-6) :301-310
[10]   Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine [J].
Belanger, Anne-Sophie ;
Caron, Patrick ;
Harvey, Mario ;
Zimmerman, Peter A. ;
Mehlotra, Rajeev K. ;
Guillemette, Chantal .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) :1793-1796